Lydia Eleanor Wiedel Pace, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Early Detection of Cancer | 23 | 2024 | 3238 | 3.830 |
Why?
|
Breast Neoplasms | 53 | 2025 | 21188 | 3.720 |
Why?
|
Mammography | 21 | 2024 | 2434 | 3.210 |
Why?
|
Rwanda | 17 | 2025 | 673 | 2.090 |
Why?
|
Contraception | 10 | 2023 | 362 | 2.090 |
Why?
|
Contraceptive Agents, Female | 5 | 2019 | 123 | 1.750 |
Why?
|
Intrauterine Devices | 4 | 2019 | 115 | 1.550 |
Why?
|
Abortion, Legal | 4 | 2022 | 121 | 1.490 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2021 | 1189 | 1.390 |
Why?
|
Insurance Coverage | 10 | 2022 | 1946 | 1.070 |
Why?
|
Cost Sharing | 5 | 2019 | 409 | 1.010 |
Why?
|
Contraceptive Agents | 4 | 2023 | 148 | 0.970 |
Why?
|
Family Planning Services | 4 | 2021 | 279 | 0.930 |
Why?
|
Medicaid | 10 | 2022 | 2843 | 0.930 |
Why?
|
Mass Screening | 10 | 2024 | 5457 | 0.870 |
Why?
|
General Practitioners | 2 | 2022 | 103 | 0.870 |
Why?
|
Women's Health Services | 2 | 2017 | 88 | 0.860 |
Why?
|
Breast | 8 | 2023 | 1976 | 0.830 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2023 | 2044 | 0.830 |
Why?
|
Women's Health | 7 | 2023 | 2081 | 0.750 |
Why?
|
Rural Population | 6 | 2025 | 2325 | 0.750 |
Why?
|
Female | 95 | 2025 | 397515 | 0.650 |
Why?
|
Travel | 1 | 2025 | 805 | 0.620 |
Why?
|
Deductibles and Coinsurance | 1 | 2021 | 316 | 0.620 |
Why?
|
Contraception Behavior | 2 | 2023 | 187 | 0.600 |
Why?
|
Eligibility Determination | 1 | 2022 | 421 | 0.600 |
Why?
|
Rectum | 2 | 2019 | 900 | 0.560 |
Why?
|
Condoms | 1 | 2019 | 338 | 0.550 |
Why?
|
Abortion, Induced | 1 | 2022 | 471 | 0.530 |
Why?
|
Primary Health Care | 5 | 2022 | 4748 | 0.530 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2018 | 260 | 0.510 |
Why?
|
Humans | 102 | 2025 | 768970 | 0.480 |
Why?
|
Physicians | 3 | 2020 | 4607 | 0.480 |
Why?
|
Government Regulation | 1 | 2019 | 525 | 0.480 |
Why?
|
Maternal Mortality | 1 | 2017 | 310 | 0.470 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2019 | 1126 | 0.470 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 625 | 0.470 |
Why?
|
Delayed Diagnosis | 4 | 2020 | 468 | 0.460 |
Why?
|
United States | 32 | 2024 | 73186 | 0.460 |
Why?
|
Neoplasm Staging | 3 | 2025 | 11262 | 0.450 |
Why?
|
Disclosure | 1 | 2019 | 755 | 0.430 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 790 | 0.430 |
Why?
|
Sexual Behavior | 3 | 2023 | 2200 | 0.420 |
Why?
|
Physical Examination | 1 | 2019 | 1262 | 0.420 |
Why?
|
Health Services Accessibility | 8 | 2025 | 5522 | 0.410 |
Why?
|
Pregnancy Outcome | 2 | 2024 | 2974 | 0.400 |
Why?
|
Politics | 1 | 2019 | 822 | 0.390 |
Why?
|
Pregnancy, Unwanted | 1 | 2011 | 24 | 0.390 |
Why?
|
Teaching | 1 | 2019 | 1171 | 0.390 |
Why?
|
Insurance Claim Review | 4 | 2022 | 746 | 0.380 |
Why?
|
Insurance, Health | 4 | 2021 | 2518 | 0.380 |
Why?
|
Adult | 40 | 2025 | 223851 | 0.370 |
Why?
|
Health Benefit Plans, Employee | 1 | 2013 | 332 | 0.360 |
Why?
|
False Positive Reactions | 3 | 2019 | 963 | 0.360 |
Why?
|
Motivation | 1 | 2020 | 2025 | 0.350 |
Why?
|
Ultrasonography, Mammary | 3 | 2022 | 241 | 0.350 |
Why?
|
Preoperative Care | 1 | 2019 | 2258 | 0.350 |
Why?
|
Patient Acceptance of Health Care | 4 | 2023 | 3235 | 0.350 |
Why?
|
Middle Aged | 35 | 2025 | 223737 | 0.340 |
Why?
|
Developing Countries | 6 | 2024 | 2911 | 0.330 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2021 | 4056 | 0.330 |
Why?
|
Maine | 4 | 2022 | 146 | 0.330 |
Why?
|
Practice Guidelines as Topic | 5 | 2024 | 7460 | 0.320 |
Why?
|
Health Expenditures | 3 | 2023 | 2396 | 0.320 |
Why?
|
Massachusetts | 6 | 2022 | 8894 | 0.320 |
Why?
|
Patient Participation | 1 | 2018 | 1448 | 0.320 |
Why?
|
Africa South of the Sahara | 4 | 2020 | 753 | 0.310 |
Why?
|
Cancer Care Facilities | 2 | 2025 | 428 | 0.310 |
Why?
|
Genetic Testing | 2 | 2021 | 3591 | 0.300 |
Why?
|
BRCA2 Protein | 3 | 2022 | 803 | 0.300 |
Why?
|
Delivery of Health Care | 9 | 2024 | 5375 | 0.280 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2784 | 0.280 |
Why?
|
Drug Implants | 2 | 2019 | 230 | 0.270 |
Why?
|
Pregnancy | 14 | 2024 | 30265 | 0.270 |
Why?
|
Referral and Consultation | 5 | 2023 | 3628 | 0.270 |
Why?
|
Decision Making | 2 | 2018 | 3953 | 0.270 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1156 | 0.270 |
Why?
|
Health Personnel | 1 | 2019 | 3383 | 0.250 |
Why?
|
Health Status Disparities | 1 | 2017 | 1886 | 0.250 |
Why?
|
Young Adult | 16 | 2022 | 60131 | 0.250 |
Why?
|
Retrospective Studies | 12 | 2025 | 81903 | 0.250 |
Why?
|
Adolescent | 19 | 2023 | 89244 | 0.240 |
Why?
|
Patient Advocacy | 1 | 2007 | 362 | 0.240 |
Why?
|
Prescription Drugs | 1 | 2012 | 635 | 0.240 |
Why?
|
Aged | 21 | 2025 | 171786 | 0.240 |
Why?
|
Papillomavirus Vaccines | 2 | 2021 | 497 | 0.240 |
Why?
|
Medication Adherence | 1 | 2016 | 2192 | 0.230 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3709 | 0.220 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26395 | 0.220 |
Why?
|
Biopsy | 6 | 2022 | 6805 | 0.200 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3421 | 0.180 |
Why?
|
Postal Service | 1 | 2020 | 96 | 0.170 |
Why?
|
Ultrasonography | 3 | 2020 | 6002 | 0.170 |
Why?
|
Health Priorities | 1 | 2023 | 380 | 0.170 |
Why?
|
Philadelphia | 1 | 2020 | 271 | 0.170 |
Why?
|
Medical Tourism | 1 | 2020 | 51 | 0.170 |
Why?
|
Birth Intervals | 1 | 2019 | 55 | 0.160 |
Why?
|
Legislation, Medical | 1 | 2019 | 99 | 0.160 |
Why?
|
Hospitals, District | 1 | 2019 | 114 | 0.150 |
Why?
|
Colonoscopy | 3 | 2019 | 1410 | 0.150 |
Why?
|
Ethiopia | 4 | 2021 | 485 | 0.150 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1672 | 0.140 |
Why?
|
Risk Factors | 11 | 2021 | 74976 | 0.140 |
Why?
|
Tamoxifen | 1 | 2022 | 967 | 0.140 |
Why?
|
Private Sector | 1 | 2020 | 396 | 0.140 |
Why?
|
Women's Rights | 1 | 2017 | 66 | 0.140 |
Why?
|
Health Plan Implementation | 1 | 2020 | 338 | 0.140 |
Why?
|
Income | 4 | 2023 | 1879 | 0.140 |
Why?
|
Social Stigma | 1 | 2023 | 788 | 0.140 |
Why?
|
Aged, 80 and over | 10 | 2019 | 59739 | 0.130 |
Why?
|
China | 1 | 2022 | 2395 | 0.130 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 390 | 0.130 |
Why?
|
Age Factors | 5 | 2019 | 18435 | 0.120 |
Why?
|
Time Factors | 6 | 2021 | 40261 | 0.120 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 954 | 0.120 |
Why?
|
Mentors | 1 | 2020 | 672 | 0.120 |
Why?
|
Health Policy | 2 | 2021 | 2700 | 0.120 |
Why?
|
Students, Medical | 1 | 2008 | 1964 | 0.120 |
Why?
|
Developed Countries | 1 | 2017 | 452 | 0.120 |
Why?
|
Health Facilities | 1 | 2019 | 577 | 0.120 |
Why?
|
Program Evaluation | 1 | 2023 | 2508 | 0.120 |
Why?
|
Self Report | 2 | 2019 | 3773 | 0.120 |
Why?
|
Adolescent Behavior | 1 | 2023 | 1188 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3554 | 0.120 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4919 | 0.110 |
Why?
|
Qualitative Research | 3 | 2023 | 3143 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 2017 | 377 | 0.110 |
Why?
|
Risk | 3 | 2023 | 9621 | 0.110 |
Why?
|
Comprehension | 1 | 2019 | 639 | 0.110 |
Why?
|
Hospitals, Rural | 1 | 2015 | 176 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1119 | 0.100 |
Why?
|
Needs Assessment | 1 | 2019 | 1143 | 0.100 |
Why?
|
Cohort Studies | 5 | 2022 | 41808 | 0.100 |
Why?
|
Organizational Innovation | 1 | 2015 | 540 | 0.100 |
Why?
|
Medically Uninsured | 2 | 2020 | 841 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1076 | 0.100 |
Why?
|
Review Literature as Topic | 1 | 2014 | 298 | 0.100 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3928 | 0.100 |
Why?
|
Withholding Treatment | 1 | 2016 | 620 | 0.100 |
Why?
|
Maternal Health Services | 2 | 2020 | 472 | 0.100 |
Why?
|
Teratogens | 1 | 2012 | 119 | 0.100 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2015 | 392 | 0.100 |
Why?
|
Peru | 2 | 2022 | 891 | 0.090 |
Why?
|
Pregnancy Complications | 2 | 2024 | 2974 | 0.090 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 561 | 0.090 |
Why?
|
New Hampshire | 2 | 2021 | 174 | 0.090 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2013 | 348 | 0.090 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5544 | 0.090 |
Why?
|
Postpartum Period | 3 | 2022 | 1198 | 0.090 |
Why?
|
Hospitals | 3 | 2023 | 3904 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2020 | 1812 | 0.090 |
Why?
|
Life Expectancy | 1 | 2017 | 1249 | 0.090 |
Why?
|
Educational Status | 2 | 2019 | 2515 | 0.090 |
Why?
|
South Carolina | 2 | 2021 | 113 | 0.090 |
Why?
|
Premature Birth | 1 | 2022 | 1830 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1226 | 0.080 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1364 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2171 | 0.080 |
Why?
|
Drugs, Generic | 1 | 2013 | 455 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 4040 | 0.080 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2909 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2019 | 2784 | 0.070 |
Why?
|
Medicare | 2 | 2023 | 6888 | 0.070 |
Why?
|
Congenital Abnormalities | 1 | 2012 | 704 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3931 | 0.070 |
Why?
|
Risk Assessment | 3 | 2023 | 24333 | 0.070 |
Why?
|
Survivors | 1 | 2017 | 2383 | 0.070 |
Why?
|
Neoplasms | 3 | 2024 | 22389 | 0.070 |
Why?
|
Emigrants and Immigrants | 1 | 2013 | 551 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1191 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 3275 | 0.060 |
Why?
|
Minority Groups | 1 | 2013 | 1216 | 0.060 |
Why?
|
Registries | 1 | 2022 | 8384 | 0.060 |
Why?
|
Colorectal Neoplasms | 3 | 2019 | 6982 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2565 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3269 | 0.060 |
Why?
|
Models, Statistical | 2 | 2019 | 5110 | 0.060 |
Why?
|
Male | 14 | 2023 | 365203 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2360 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10633 | 0.060 |
Why?
|
Residence Characteristics | 1 | 2013 | 2121 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 36854 | 0.050 |
Why?
|
Colonography, Computed Tomographic | 1 | 2004 | 170 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4860 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5892 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39394 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54962 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4339 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 8094 | 0.040 |
Why?
|
Africa, Eastern | 1 | 2020 | 76 | 0.040 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2001 | 184 | 0.040 |
Why?
|
Incidence | 2 | 2016 | 21547 | 0.040 |
Why?
|
Linear Models | 2 | 2021 | 5891 | 0.040 |
Why?
|
Jews | 1 | 2021 | 359 | 0.040 |
Why?
|
Insurance Benefits | 1 | 2021 | 187 | 0.040 |
Why?
|
Chemoprevention | 1 | 2022 | 326 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13594 | 0.040 |
Why?
|
Health Services | 1 | 2024 | 755 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 7861 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 508 | 0.040 |
Why?
|
Tanzania | 1 | 2023 | 1407 | 0.040 |
Why?
|
Aromatase Inhibitors | 1 | 2022 | 519 | 0.040 |
Why?
|
Indians, North American | 1 | 2021 | 354 | 0.040 |
Why?
|
Risk-Taking | 1 | 2023 | 1023 | 0.040 |
Why?
|
Policy | 1 | 2021 | 514 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10400 | 0.030 |
Why?
|
Advisory Committees | 1 | 2021 | 797 | 0.030 |
Why?
|
Employment | 1 | 2023 | 1114 | 0.030 |
Why?
|
Epidemiologic Research Design | 1 | 2019 | 368 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 576 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 921 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1669 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2020 | 1140 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 873 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1737 | 0.030 |
Why?
|
Counseling | 1 | 2021 | 1554 | 0.030 |
Why?
|
San Francisco | 1 | 2013 | 166 | 0.030 |
Why?
|
Sexually Transmitted Diseases | 1 | 2018 | 668 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1642 | 0.030 |
Why?
|
Health Resources | 1 | 2019 | 951 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2001 | 2734 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3214 | 0.020 |
Why?
|
National Health Programs | 1 | 2013 | 442 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3112 | 0.020 |
Why?
|
Telephone | 1 | 2013 | 630 | 0.020 |
Why?
|
Poverty | 1 | 2021 | 2720 | 0.020 |
Why?
|
Quality Improvement | 1 | 2024 | 3860 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3438 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 30046 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 2308 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3782 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4095 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3629 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2932 | 0.020 |
Why?
|
Medical Oncology | 1 | 2019 | 2350 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13021 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2020 | 4530 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 4055 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12095 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26428 | 0.010 |
Why?
|
Child | 2 | 2021 | 80960 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13318 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8749 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20776 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18068 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2016 | 4879 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15879 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30266 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2001 | 1998 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65480 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2001 | 3411 | 0.000 |
Why?
|